Name: BREAKING: 737 Possible Blood-Clotting Incidents Reported With Pfizer And Moderna COVID-19 Vaccines
Brand: thewashingtongazette.com
SKU: thewashingtongazette-com-36
Availability: OnlineOnly

critic

BREAKING: 737 Possible Blood-Clotting Incidents Reported With Pfizer And Moderna COVID-19 Vaccines

preview

powered byWhen the United States government’s Food and Drug Administration earlier this week the giving of Johnson &amp; Johnson’s experimental coronavirus vaccine shots because of the developing of blood clots in people who have received the shots, I if we were seeing an example of regulatory favoritism for the new mRNA technology shots over more traditional vaccine shots such as the Johnson &amp; Johnson shots. The question arises because the US government is still encouraging everyone to take experimental mRNA from Moderna and Pfizer-BioNTech regarding which there are also many reports of injury and death.While a variety or injuries and deaths have been reported after people have taken experimental coronavirus vaccine shots developed respectively by the three companies, if you focus in on just blood clot problems, those problems appear to arise after Moderna and Pfizer-BioNTech experimental coronavirus shots as well as after Johnson &amp; Johnson shots.Megan Redshaw Friday at the Children’s Health Defense website regarding adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) related to the blood clots in people who had taken any one of the three companies’ experimental vaccines:&nbsp;queried the VAERS data for a series of adverse events associated with the formation of clotting disorders and other related conditions. VAERS yielded a total of&nbsp;&nbsp;for all three vaccines from Dec. 14, 2020, through April 8.Of the 795 cases reported, there were&nbsp;&nbsp;attributed to Pfizer,&nbsp;&nbsp;with Moderna and&nbsp;&nbsp;with J&amp;J — far more than the eight J&amp;J cases under investigation,&nbsp;&nbsp;added Wednesday. As&nbsp;&nbsp;today, although the J&amp;J and AstraZeneca COVID vaccines have been under the microscope for their potential to cause blood clots, mounting evidence suggests the Pfizer and Moderna vaccines also cause clots and related blood disorders. U.S. regulatory officials&nbsp;&nbsp;to the problem as far back as December 2020.So why the different treatment for the Moderna and Pfizer-BioNTech shots?powered byHELP STOP THE SPREAD OF FAKE NEWS!SHARE our articles and like our page and follow us on !Created By | Distributed By

powered byWhen the United States government’s Food and Drug Administration earlier this week the giving of Johnson &amp; Johnson’s experimental coronavirus vaccine shots because of the developing of blood clots in people who have received the shots, I if we were seeing an example of regulatory favoritism for the new mRNA technology shots over more traditional vaccine shots such as the Johnson &amp; Johnson shots. The question arises because the US government is still encouraging everyone to take experimental mRNA from Moderna and Pfizer-BioNTech regarding which there are also many reports...

public

thewashingtongazette.com

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

BREAKING: 737 Possible Blood-Clotting Incidents Reported With Pfizer And Moderna COVID-19 Vaccines

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS